1)厚生省特定疾患「呼吸不全」調査研究班(編):呼吸不全—診断と治療のためのガイドライン.pp10-13,メディカルレビュー社,1996.
2)日本呼吸器学会COPDガイドライン第4版 作成委員会(編):COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン,第4版.メディカルレビュー社,2013.
3)Global Initiative for Chronic Obstructive Lung Disease. https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf
4)Barnes PJ : Chronic obstructive pulmonary disease ; effects beyond the lungs. PLoS Med 7(3) : e1000220, 2010. PMID 20305715
5)Smith MC, et al : Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 9 : 871-888, 2014. PMID 25210449
6)Waschki B, et al : Physical activity is the strongest predictor of all-cause mortality in patients with COPD ; a prospective cohort study. Chest 140(2) : 331-342, 2011. PMID 21273294
7)Barnes PJ : Chronic obstructive pulmonary disease. N Engl J Med 343(4) : 269-280, 2000. PMID 10911010
8)MacNee W : Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2(4) : 258-266, 2005. PMID 16267346
9)Davies CE, et al : Neurological effects of oxygen in chronic cor pulmonale. Lancet 2(6585) : 883-885, 1949. PMID 15393115
10)Rialp G, et al : Role of respiratory drive in hyperoxia-induced hypercapnia in ready-to-wean subjects with COPD. Respir Care 60(3) : 328-334, 2015.
11)Dunham-Snary KJ, et al : Hypoxic pulmonary vasoconstriction ; from molecular mechanisms to medicine. Chest 151(1) : 181-192, 2017. PMID 27645688
12)Ledere DJ, et al : Idiopathic pulmonary fibrosis. N Engl J Med 378(19):1811-1823, 2018. PMID 29742380
13)Shlobin OA, et al : Pulmonary hypertension in diffuse parenchymal lung diseases. Chest 151(1) : 204-214, 2017. PMID 27554299
14)Klinger JR, et al : Right ventricular dysfunction in chronic obstructive pulmonary disease ; evaluation and management. Chest 99(3) : 715-723, 1991. PMID 1995228